ArticleMethods in molecular biology (Clifton, N.J.)2025
Phage Display Isolation of VHH Antibodies Targeting Capsular Polysaccharides of Intratumor Bacteria.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Phage display, a well-established and powerful tool, has been used to identify and isolate antibody fragments against a range of diverse cancer-related antigen types. Nonetheless, the availability of specific antibodies and antibody fragments against carbohydrate antigens remains low and insufficient. Bacteria found within cancer and immune cells affect tumorigenesis, progression, and shaping of the immunosuppressive microenvironment. Yet, their identification primarily relies on nucleic acid-based sequencing techniques at the species level, leaving a significant gap in molecular tools that distinguish bacterial strains and serotypes. This chapter provides a comprehensive protocol for phage display-based VHH antibodies identification against the capsular polysaccharides that define bacterial serotypes based on their composition and structure. We aim to illuminate a path for developing antibody fragments that will enable the targeting of specific intracellular bacterial strains and serotypes in tumor and immune cells, thereby unraveling their role and contribution to cancer biology.
Indexed as
Identifiers
40266526What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.